1xxf

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1xxf.gif|left|200px]]
+
{{Seed}}
 +
[[Image:1xxf.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1xxf| PDB=1xxf | SCENE= }}
{{STRUCTURE_1xxf| PDB=1xxf | SCENE= }}
-
'''Crystal Structure of the FXIa Catalytic Domain in Complex with Ecotin Mutant (EcotinP)'''
+
===Crystal Structure of the FXIa Catalytic Domain in Complex with Ecotin Mutant (EcotinP)===
-
==Overview==
+
<!--
-
Thrombosis can lead to life-threatening conditions such as acute myocardial infarction, pulmonary embolism, and stroke. Although commonly used anti-coagulant drugs, such as low molecular weight heparin and warfarin, are effective, they carry a significant risk of inducing severe bleeding complications, and there is a need for safer drugs. Activated Factor XI (FXIa) is a key enzyme in the amplification phase of the coagulation cascade. Anti-human FXI antibody significantly reduces thrombus growth in a baboon thrombosis model without bleeding problems (Gruber, A., and Hanson, S. R. (2003) Blood 102, 953-955). Therefore, FXIa is a potential target for anti-thrombosis therapy. To determine the structure of FXIa, we derived a recombinant catalytic domain of FXI, consisting of residues 370-607 (rhFXI370-607). Here we report the first crystal structure of rhFXI370-607 in complex with a substitution mutant of ecotin, a panserine protease protein inhibitor secreted by Escherichia coli, to 2.2 A resolution. The presence of ecotin not only assisted in the crystallization of the enzyme but also revealed unique structural features in the active site of FXIa. Subsequently, the sequence from P5 to P2' in ecotin was mutated to the FXIa substrate sequence, and the structures of the rhFXI370-607-ecotin mutant complexes were determined. These structures provide us with an understanding of substrate binding interactions of FXIa, the structural information essential for the structure-based design of FXIa-selective inhibitors.
+
The line below this paragraph, {{ABSTRACT_PUBMED_15545266}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 15545266 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_15545266}}
==Disease==
==Disease==
Line 41: Line 45:
[[Category: Serine protease]]
[[Category: Serine protease]]
[[Category: Substrate-like interaction]]
[[Category: Substrate-like interaction]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 15:37:43 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 08:13:43 2008''

Revision as of 05:13, 28 July 2008

Image:1xxf.png

Template:STRUCTURE 1xxf

Contents

Crystal Structure of the FXIa Catalytic Domain in Complex with Ecotin Mutant (EcotinP)

Template:ABSTRACT PUBMED 15545266

Disease

Known disease associated with this structure: Factor XI deficiency, autosomal dominant OMIM:[264900], Factor XI deficiency, autosomal recessive OMIM:[264900]

About this Structure

1XXF is a Protein complex structure of sequences from Escherichia coli and Homo sapiens. Full crystallographic information is available from OCA.

Reference

Crystal structures of the FXIa catalytic domain in complex with ecotin mutants reveal substrate-like interactions., Jin L, Pandey P, Babine RE, Gorga JC, Seidl KJ, Gelfand E, Weaver DT, Abdel-Meguid SS, Strickler JE, J Biol Chem. 2005 Feb 11;280(6):4704-12. Epub 2004 Nov 15. PMID:15545266

Page seeded by OCA on Mon Jul 28 08:13:43 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1xxf"
Personal tools